{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:09:45Z","timestamp":1790442585161,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"German Federal Ministry of Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Ministry for Higher Education, Research and the Arts of the Free State of Saxony"},{"name":"German Consortium for Translational Cancer Research"},{"name":"National Center for Tumor Diseases"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.radonc.2019.02.020","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T11:30:26Z","timestamp":1552131026000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy"],"prefix":"10.1016","volume":"135","author":[{"given":"Steffen","family":"L\u00f6ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-1721","authenticated-orcid":false,"given":"Annett","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekatrin","family":"Seidlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bandurska-Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Gudziol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo B.","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Z\u00f6phel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-9050","authenticated-orcid":false,"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.02.020_b0005","first-page":"297","article-title":"Tumor hypoxia in cancer therapy","volume":"435","author":"Brown","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.radonc.2019.02.020_b0010","unstructured":"Durand RE. The influence of microenvironmental factors during cancer therapy. In Vivo n.d.;8:691\u2013702."},{"key":"10.1016\/j.radonc.2019.02.020_b0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/djj306","article-title":"Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs","volume":"98","author":"Hicks","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2019.02.020_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(98)90327-0","article-title":"Conventional cancer therapy: promise broken or promise delayed?","volume":"351","author":"Tannock","year":"1998","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.radonc.2019.02.020_b0025","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: a key player in antitumor immune response. A review in the theme: Cellular responses to hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.radonc.2019.02.020_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2012.171","article-title":"Imaging hypoxia to improve radiotherapy outcome","volume":"9","author":"Horsman","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0305-7372(03)00003-3","article-title":"Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies","volume":"29","author":"Shannon","year":"2003","journal-title":"Cancer Treat Rev"},{"issue":"Suppl 1","key":"10.1016\/j.radonc.2019.02.020_b0050","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck\u2013a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0060","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.2011.35.9315","article-title":"Accelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trial","volume":"30","author":"Janssens","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0065","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0360-3016(86)90267-1","article-title":"SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells","volume":"12","author":"Zeman","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.02.020_b0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1259\/0007-1285-39-460-302","article-title":"Extreme hypoxia; its effect on the survival of mammalian cells irradiated at high and low dose-rates","volume":"39","author":"Hall","year":"1966","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2019.02.020_b0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.02.020_b0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2006.11.061","article-title":"Hypoxia dose painting by numbers: a planning study","volume":"68","author":"Thorwarth","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.02.020_b0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2009.02.020","article-title":"Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study","volume":"91","author":"Petit","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2014.02.005","article-title":"Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice","volume":"111","author":"Sch\u00fctze","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.radonc.2013.08.031","article-title":"Hypoxia imaging with [18F]HX4 PET in NSCLC patients: defining optimal imaging parameters","volume":"109","author":"Zegers","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2014.09.045","article-title":"A comparative study of the hypoxia PET tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a preclinical tumor model","volume":"91","author":"Peeters","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2017.08.010","article-title":"Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging","author":"L\u00f6ck","year":"2017","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-5-152","article-title":"Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer","volume":"5","author":"Thorwarth","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0125","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/1078-0432.CCR-05-1773","article-title":"Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer","volume":"12","author":"Rajendran","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12149-011-0508-9","article-title":"18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma","volume":"25","author":"Kikuchi","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.radonc.2019.02.020_b0135","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2967\/jnumed.109.062638","article-title":"Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI","volume":"50","author":"Dirix","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2019.02.020_b0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.radonc.2007.05.014","article-title":"Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer","volume":"83","author":"Eschmann","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0145","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of 18F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Servagi-Vernat","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2019.02.020_b0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2015.09.015","article-title":"Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome","volume":"117","author":"Wiedenmann","year":"2015","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0155","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0160","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","article-title":"A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer","volume":"19","author":"Eustace","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrg2665","article-title":"Generating specificity and diversity in the transcriptional response to hypoxia","volume":"10","author":"Lendahl","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.radonc.2019.02.020_b0170","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","article-title":"Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene","volume":"102","author":"Buffa","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0180","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2005.07.010","article-title":"Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy coo","volume":"23","author":"Budach","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3413\/nukmed-00328-10-07","article-title":"Two or four hour [18F]FMISO-PET in HNSCC. When is the contrast best?","volume":"50","author":"Abolmaali","year":"2011","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.radonc.2019.02.020_b0190","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-14-1524","article-title":"In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET\/CT imaging","volume":"20","author":"Zegers","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2005.06.019","article-title":"Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?","volume":"76","author":"Yaromina","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0200","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/bjc.2015.284","article-title":"Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole","volume":"113","author":"Dhani","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1667\/RR0719.1","article-title":"Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers","volume":"167","author":"Ljungkvist","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2006.08.010","article-title":"Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies","volume":"81","author":"Yaromina","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2006.07.023","article-title":"Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors","volume":"80","author":"Troost","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0220","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00259-008-0772-7","article-title":"Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts","volume":"35","author":"Troost","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2019.02.020_b0225","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1007\/s00259-014-2776-9","article-title":"Correlation between 18F-fluoromisonidazole PET and expression of HIF-1\u03b1 and VEGF in newly diagnosed and recurrent malignant gliomas","volume":"41","author":"Kawai","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2019.02.020_b0230","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/1078-0432.CCR-07-4995","article-title":"Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival","volume":"14","author":"Spence","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MNM.0000000000000010","article-title":"Correlation of 18F-fluoromisonidazole PET findings with HIF-1\u03b1 and p53 expressions in head and neck cancer","volume":"35","author":"Norikane","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.radonc.2019.02.020_b0240","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2967\/jnumed.112.114355","article-title":"18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1\u03b1 expression in oral squamous cell carcinoma","volume":"54","author":"Sato","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2019.02.020_b0245","article-title":"18F-Fluoromisonidazole in tumor hypoxia imaging","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2019.02.020_b0250","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/bjc.2017.66","article-title":"Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinoma","volume":"116","author":"Suh","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199970","article-title":"18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer","volume":"13","author":"Heiden","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2019.02.020_b0260","first-page":"365","article-title":"PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence","volume":"4","author":"Lopci","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2019.02.020_b0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13058-018-0970-6","article-title":"Intracellular hypoxia measured by 18F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer","volume":"20","author":"Asano","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0270","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00259-002-1096-7","article-title":"[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression","volume":"30","author":"Rajendran","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2019.02.020_b0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1535-6108(04)00112-6","article-title":"Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression","volume":"5","author":"Chung","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2019.02.020_b0280","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3174\/ajnr.A3159","article-title":"Application of 62 Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1\u03b1 expression in patients with glioma","volume":"34","author":"Tateishi","year":"2013","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.radonc.2019.02.020_b0290","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.010","article-title":"Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck","volume":"102","author":"Toustrup","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0295","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","article-title":"Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers","volume":"67","author":"Winter","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0300","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2019.02.020_b0305","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2019.02.020_b0310","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.radonc.2007.04.020","article-title":"Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation","volume":"83","author":"Yaromina","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0315","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/mrm.10318","article-title":"How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors?","volume":"48","author":"Baudelet","year":"2002","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2019.02.020_b0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2018.07.020","article-title":"CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer","volume":"130","author":"Leger","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0325","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2017.04.019","article-title":"Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV\/p16 negative squamous cell carcinoma of the head and neck: results of the benchmark case procedure","volume":"123","author":"Christiaens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.02.020_b0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.radonc.2017.04.004","article-title":"Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial","volume":"124","author":"Welz","year":"2017","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:07:33Z","timestamp":1759122453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019301021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":66,"alternative-id":["S0167814019301021"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.02.020","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}